Author: Minichart

us corporate news

Spruce Biosciences Reports 2025 Financial Results, Advances TA-ERT for MPS IIIB with FDA, and Secures $50M Growth Capital

Minichart

March 9, 2026

Spruce Biosciences 2025 Results & Corporate Update: Detailed...

Continue Reading 0

us corporate news

Abeona Therapeutics Announces Momentum in ZEVASKYN® Gene Therapy Launch for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Minichart

March 9, 2026

Abeona Therapeutics Provides Detailed Business Update on ZEV...

Continue Reading 0

us corporate news

Creative Media & Community Trust Corporation Reports Q4 2025 Results and Announces Balance Sheet, FFO Improvements

Minichart

March 9, 2026

Creative Media & Community Trust Corporation Reports Q4 2025...

Continue Reading 0

us corporate news

Korro Bio Raises $85 Million in Oversubscribed PIPE Financing to Advance RNA Editing Therapies and Extend Cash Runway into 2028

Minichart

March 9, 2026

Korro Bio Announces Oversubscribed \$85 Million Private Plac...

Continue Reading 0

us corporate news

FuelCell Energy Reports 61% Q1 2026 Revenue Growth, Expands Data Center Power Strategy and Strengthens Liquidity

Minichart

March 9, 2026

FuelCell Energy Reports Strong Q1 2026 Revenue Growth and Ad...

Continue Reading 0

us corporate news

Lightpath Fiber Issuer LLC Secured Fiber Network Revenue Notes Indenture Agreement – Definitions, Covenants, and Regulatory Compliance (2026)

Minichart

March 9, 2026

Optimum Communications, Inc. - Detailed Investor Report ...

Continue Reading 0

us corporate news

Xenon Pharmaceuticals Announces Positive Phase 3 Results for Azetukalner in Focal Onset Seizures, Plans FDA Submission in Q3 2026 12

Minichart

March 9, 2026

Xenon Pharmaceuticals Announces Exceptionally Positive Phase...

Continue Reading 0

us corporate news

Lisata Therapeutics to Be Acquired by Kuva Labs for $5.00 Per Share Plus Potential $1.00 CVR in 2026 Merger Deal

Minichart

March 9, 2026

Lisata Therapeutics to be Acquired by Kuva Labs in \$5.00 pe...

Continue Reading 0

us corporate news

Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results, Highlights Promising CRB-701 and CRB-913 Clinical Updates and Extends Cash Runway Into 2028

Minichart

March 9, 2026

Corbus Pharmaceuticals Q4 2025 Earnings and Corporate Update...

Continue Reading 0

us corporate news

Heritage Insurance Holdings Reports Record Q4 and Full-Year 2025 Results with 228% Net Income Growth and Strategic Expansion Plans

Minichart

March 9, 2026

Heritage Insurance Holdings Reports Record Fourth Quarter an...

Continue Reading 0